interferon beta 1b

interferon beta 1b

a purified protein containing 165 amino acids (MW approximately 18,500) with antiviral and immunomodulatory effects, used in the treatment of relapsing-remitting multiple sclerosis to reduce the frequency of clinical exacerbations.
References in periodicals archive ?
Contract notice: framework agreement for the supply of interferon beta 1b (doe) for all osakidetza service organizations
Previous research into the issue showed that certain medications like interferon beta 1b (Betaseron), mitoxantrone (Novantrone)and natalizumab (Tysabri) can be used to treat patients with secondary progressive MS experiencing frequent attacks.
Supply of medicinal products to the therapeutic program for the treatment of multiple sclerosis in the task division: Task 1 - interferon beta 1 a task 2 - interferon beta 1b task 3 - glatiramer acetate task 4 - interferon beta 1a task 5 - dimethyl fumarate.
According to data presented today at the European Neurological Society Meeting, Vienna, COPAXONE(R) produced the largest reduction, relative to pre-treatment in annual relapse rates at two, three, and four years after the initiation of treatment, when compared to three beta interferon therapies beta 1a (Avonex(R)), 22 microgram interferon 1a (Rebif(R) 22), and interferon beta 1b (Betaferon(R)) therapies.
Compared to interferon beta 1b (Betaferon(R)), interferon beta 1a (Avonex(R)), and 22 microgram interferon beta 1a (Rebif(R) 22), COPAXONE(R) produced a statistically significant greater reduction in annual relapse rates at 24 months after initiation of treatment versus pre-study rates.
Tenders invited for Injection, recombinant interferon beta 1b 250 mcg or its biosimlar (box of 15 vials
Tenders are invited for Inj Recombinant Interferon Beta 1B 250 Mcg (Box Of 15 Vials)
Limited Tenders are invited for Inj Interferon Beta 1B 250 Mg Inj
Contract notice: Supply of the drug interferon beta 1b for all service organizations osakidetza.

Full browser ?